← Back

Medline Inc. Class A Common Stock

Medline Inc. manufactures med-surg products serving the hospital, surgery centers, physician offices, post-acute facilities, and nursing home sites of care in the United States and Internationally. It operates through two segments: Medline Brand and Supply Chain Solutions. The Medline Brand segment procures and manufactures products from three product categories include surgical solutions, front line care, and laboratory and diagnostics. Its front line care offers med-surg products for patient-facing needs, including wound care products, exam gloves, skin care and incontinence products, environment cleaning supplies, textiles, hand sanitizer, durable medical equipment, patient plastics, and decolonization and infection control products. Its surgical solutions provide operating room and perioperative environment product solutions, including surgical procedure trays, drapes and gowns, personal protective equipment, sterile wraps, surgical instruments, surgeon's gloves, procedure kits, and orthopedic implants. Its laboratory and diagnostics offer laboratory and diagnostic product solutions, including point of care testing, analyzers and instrumentation, lab and diagnostic consumables, diagnostic instruments, vital signs monitors, and anatomic pathology and phlebotomy products. It provides its products to domestic and international consumers. The Supply Chain Solutions segment procures and distributes a variety of third-party products from national brands. It provides logistics and supply chain optimization services to domestic and international consumers. It also provides supply chain optimization services, such as consulting engagements, outsourced warehouse and technology management, put-away-ready packaging, third-party logistics, inventory rationalization, and route planning. The company was founded in 1966 and is based in Northfield, Illinois.

Price · split & dividend adjusted
News & notes moving MDLN
MDLN▼

S&P 500 Futures Edge Higher as Inflation Worries Ease

US stock futures are pointing higher, with E mini S&P 500 contracts up about 0.2% and Dow futures also in positive territory, as softer inflation expectations ease borrowing cost fears. UK gilt yields slipped below 4.9% and US 10-year Treasury yields hover near 4.6%, signaling that rates may not rise as sharply as feared. Purchasing manager indexes across Europe and Japan show services and manufacturing activity just above the growth line. Among top movers, Shopify jumped 16.98% after a strong Q2 report and analyst upgrades, Bending Spoons surged 16.82% on European expansion plans, and Agnico Eagle Mines gained 9.85% on fresh analyst attention. On the downside, Space Exploration Technologies fell 13.61% after posting a quarterly loss, Medline declined 12.79% on weaker year-over-year earnings, and Astera Labs dropped 11.96% following mixed analyst updates. Today's earnings slate includes Cloudflare, Atlassian, Twilio, Roku, Warner Bros. Discovery, Airbnb, Monster Beverage, and Ralph Lauren, while China inflation data due Sunday and Berkshire Hathaway's Q2 results on Saturday are also on the radar.
BSP ▲SHOP ▲AEM ▲ALAB ▼MDLN ▼SPCX ▼
Simply Wall St·20dRead more ▾
MDLN

Medline raises sales outlook but cuts EBITDA guidance after fire and tariff refunds

Medline raised its full-year organic sales growth outlook to 9% to 10% while lowering adjusted EBITDA guidance to $3.3 billion to $3.4 billion, citing operational investments, quality remediation, retail weakness, and costs from a June fire at its Tracy, California distribution center. Second-quarter net sales rose 12% to $7.7 billion, led by a 16% increase in Supply Chain Solutions and a 15% increase in U.S. acute-care sales. Adjusted EBITDA increased 13% to $1.1 billion, including a $243 million net benefit from IEEPA tariff refunds, but underlying profitability was pressured by higher costs. The Tracy fire reduced first-half net income by $336 million, and the company expects an additional $50 million to $100 million in related costs during the second half. Medline is expanding its California distribution network and expects its footprint to reach nearly 5 million square feet by mid-2027.
MDLN
MarketBeat·21dRead more ▾
MDLN▲

Medline leases two new Northern California distribution centers totaling over 1.6 million square feet

Medline announced a lease agreement for two new distribution centers in Northern California, totaling over 1.6 million square feet of space. This move replaces a 1-million-square-foot facility destroyed by fire on June 11 and represents a 45% expansion of the company's customer-facing footprint in the region compared to one month ago. The new capacity includes a 925,000-square-foot warehouse in Tracy available for immediate occupancy and a 709,000-square-foot facility in Stockton scheduled to open in January 2027. The Tracy site is being prepared to integrate AI-powered logistics technologies and will soon support deliveries through Medline's dedicated truck fleet. The company expects its total distribution footprint in California to reach nearly 5 million square feet by mid-2027, supported by an additional 1-million-square-foot facility under construction in Perris.
MDLN ▲
Insider Monkey·45dRead more ▾
MDLN▼

Pomerantz Law Firm Investigates Medline Industries Over Potential Securities Fraud

Pomerantz LLP is investigating claims on behalf of investors of Medline Industries, Inc. regarding potential securities fraud or unlawful business practices. The investigation follows a June 2, 2026 FDA warning letter citing significant violations of Current Good Manufacturing Practice regulations, including failure to thoroughly investigate batch discrepancies. On that news, Medline’s stock fell $2.56 per share, or 7.16%, to close at $33.19 per share.
MDLN ▼
GlobeNewswire·50dRead more ▾
MDLN▼

ICU Medical Outshines Medline as a Value Stock

ICU Medical is seen as a better value stock than Medline based on Zacks Investment Research analysis. ICU Medical holds a Zacks Rank of #2 (Buy) and a Value grade of B, while Medline has a Zacks Rank of #3 (Hold) and a Value grade of C. ICU Medical's forward P/E ratio stands at 16.90 compared to Medline's 24.08, and its PEG ratio is 1.54 versus Medline's 5.19. Additionally, ICU Medical's price-to-book ratio is 1.63, lower than Medline's 2.47. The improving earnings outlook and stronger valuation metrics make ICU Medical the preferred choice for value investors.
ICUI ▲MDLN ▼
Zacks Investment Research·69dRead more ▾
© 2026 MarketDXAsset